Novo Nordisk has doubled down on position in the sickle cell disease (SCD) category with a $1.1 billion agreement to acquire Forma Therapeutics, and its therapeutic candidate etavopivat, in phase 2/3 ...
Abstract: Semantic change detection (SCD) has gradually emerged as a prominent research focus in remote sensing image processing due to its critical role in Earth observation applications. In view of ...
This is part of the ScpToolkit project. This project is published for historical reasons and no longer maintained by me. If you're seeking for a modern reincarnation take a look at ViGEm.